Rahman Md Ataur, Hannan Md Abdul, Dash Raju, Rahman Md Hasanur, Islam Rokibul, Uddin Md Jamal, Sohag Abdullah Al Mamun, Rahman Md Habibur, Rhim Hyewhon
Center for Neuroscience, Korea Institute of Science and Technology (KIST), Seoul, South Korea.
Global Biotechnology & Biomedical Research Network (GBBRN), Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh.
Front Pharmacol. 2021 May 7;12:639628. doi: 10.3389/fphar.2021.639628. eCollection 2021.
Bioactive plant derived compounds are important for a wide range of therapeutic applications, and some display promising anticancer properties. Further evidence suggests that phytochemicals modulate autophagy and apoptosis, the two crucial cellular pathways involved in the underlying pathobiology of cancer development and regulation. Pharmacological targeting of autophagy and apoptosis signaling using phytochemicals therefore offers a promising strategy that is complementary to conventional cancer chemotherapy. In this review, we sought to highlight the molecular basis of the autophagic-apoptotic pathway to understand its implication in the pathobiology of cancer, and explore this fundamental cellular process as a druggable anticancer target. We also aimed to present recent advances and address the limitations faced in the therapeutic development of phytochemical-based anticancer drugs.
源自植物的生物活性化合物对广泛的治疗应用很重要,有些还具有颇具前景的抗癌特性。进一步的证据表明,植物化学物质可调节自噬和凋亡,这是癌症发生和调控的潜在病理生物学过程中涉及的两个关键细胞途径。因此,利用植物化学物质对自噬和凋亡信号进行药理学靶向提供了一种很有前景的策略,可作为传统癌症化疗的补充。在本综述中,我们试图强调自噬 - 凋亡途径的分子基础,以了解其在癌症病理生物学中的意义,并探索这一基本细胞过程作为可药物化的抗癌靶点。我们还旨在介绍最近的进展,并解决基于植物化学物质的抗癌药物治疗开发中面临的局限性。